Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Should Income Investors Buy This Blue Chip Dividend Stock?
Tickers BMY
Tags Market News BMY Recent Press Releases
From Motley Fool
Insiders Selling Zoom Video Communications, Bristol-Myers Squibb And This Footwear Manufacturer
Tickers BMY SKX ZM
Tags Short Ideas News Pre/Market Outlook
From Benzinga
7 Best Dividend Stocks to Buy Now in May 2023
Tickers BAC BMY DE DRI
Tags TSCO Recent Press Releases DRI
From Motley Fool
Want Passive Income at a Fair Price? Consider Buying This Dividend Growth Stock
Tickers BMY NVO
Tags Recent Press Releases NVO BMY
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ABBV ALDX BMY CERE
Tags HIMS Options LLY
From Benzinga
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
Tickers BMY IMTX
Tags IMTX lymphoma Small Cap
From Benzinga
Bristol-Myers Squibb Earnings Perspective: Return On Capital Employed
Tickers BMY
Tags Market News Earnings BMY
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ALGN BMY CTLT CVS
Tags EW BZI/AUOA MDGL
From Benzinga
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down
Tickers BMY
Tags Large Cap Trading Ideas BMY
From Benzinga
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
Tickers BMY GSK LLY TNXP
Tags Penny Stocks Market News BMY
From Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
Tickers AAL ABBV AMGN AMZN
Tags QQQ PINS WOLF
From Benzinga
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
Tickers BMY LIAN
Tags Biotech Benzinga BMY
From Benzinga
Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved Breast Cancer Treatment To European Market – Interim Results Could Be Released In Second Half Of 2023
Tickers ALLR BMY
Tags Penny Stocks BMY Market News
From Benzinga
Bristol-Myers Squibb Earnings Conference Call Is Coming Up, Here's What You Need To Know
Tickers BMY
Tags Benzinga Market News BMY
From Benzinga
This Supercharged Dividend King Stock Might Soon Run Out of Steam
Tickers ABBV ABT BMY GILD
Tags BMY ABBV GILD
From Motley Fool
Want Consistently Growing Passive Income? Buy Johnson & Johnson Stock
Tickers BMY JNJ LLY
Tags JNJ Market News BMY
From Motley Fool
Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday
Tickers AUPH BMY
Tags Briefs Biotech Movers
From Benzinga
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
Tickers BMY EXEL TLRY
Tags TLRY Recent Press Releases EXEL
From Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
Tickers BMY
Tags Options BZI/UOA Markets
From Benzinga
Thinking Of Buying Healthpeak Properties? Here Are The Properties And Tenants You'd Be Adding To Your Portfolio
Tickers AMGN BMY JNJ PEAK
Tags PEAK Real Estate BMY
From Benzinga
Where Bristol-Myers Squibb Stands With Analysts
Tickers BMY
Tags Benzinga Analyst Ratings Market News
From Benzinga
Why Shares of Legend Biotech Jumped Wednesday
Tickers BMY JNJ LEGN NVS
Tags NVS JNJ Market News
From Motley Fool
Evaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients
Tickers BMY EVAX
Tags Market News News Health Care
From Benzinga
This House of Representative Just Sold Up To $265K In Bristol-Myers Squibb Stock
Tickers BMY
Tags BZI/GT Market News BMY
From Benzinga
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
Tickers ABBV BMY JNJ MRK
Tags ABBV PFE BMY
From MarketWatch
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
Tickers ALLR BIIB BMY CLOV
Tags Stocks to Sell Market News NVS
From InvestorPlace
Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
Tickers BGNE BMY ENLV MRK
Tags Enlivex Therapeutics General Biotech
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags Benzinga JNJ DD
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags Market News Hillstream BioPharma GS
From Benzinga
2 Top Stocks to Buy in April and Hold Forever
Tickers BMY SYK
Tags SYK Market News BMY
From Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.